It appears that your browser has JavaScript disabled.

This Website requires your browser to be JavaScript enabled.

Please enable JavaScript and reload this page.

multiple+sclerosis

282 Results Gelişmiş Arama

Dokümanlar (206)

Site Content (61)

Aradığınızı Bulamadınız mı?

Müşteri Hizmetleri ile
İletişime Geçin

Press Release: 150 Cyclists from Merck Millipore and Merck Serono Participated in 150 Mile Ride for MS
Merck participates in and sponsor the Bike MS: Cape Cod Getaway ride to raise money for Multiple Sclerosis (MS).
Neuroscience Multiplex Assays Using Luminex® Technology | Life Science Research | Merck
Our neuroscience multiplex assays reveal the roles of biomarkers in normal and disease states, in the study of neurological disorders like Parkinson's and ALS.
Press Release: Merck Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers
Merck today announced the global launch of the first commercially-available equine-specific multiplex assay for protein biomarkers.
Neuroscience Antibodies & Assays | Life Science Research | Merck
We have been commited to creating a validated collection of neuroscience antibodies and assays for studying development, differentiation, and disorders in the nervous system
Press Release: Merck Expands Popular Line of Guava® Flow Cytometers
Merck is expanding its popular line of Guava® flow cytometers to include a high-power modulated green laser.
Press Release: Merck Introduces MILLIPLEX® High Sensitivity Panel for Faster, More Economical Cytokine Assays
Merck today launched the MILLIPLEX® MAP Human High Sensitivity cytokine panel for faster and more cost-effective human cytokine assays.
Neurodegenerative Diseases | Life Science Research | Merck
Neurodegenerative diseases are characterized by deterioration of neurons or their myelin sheath, disrupting transmission of sensory information, movement control, and more.
Press Release: Merck Introduces First Multi-use Disposable Sterile Connectors for Biopharma at INTERPHEX 2016
Merck today announced the launch of its first-in-class Lynx® CDR connectors to improve fluid management in the biopharma industry.
Press Release: Merck Expands Industry-Leading Emprove® Program to Include Filtration and Single-Use Products
Merck has expanded its industry-leading Emprove® risk assessment program to include a selection of products for filtration and single-use processing.
Histones and Histone Modifications | Life Science Research | Merck
Histone modifications regulate DNA transcription, repair, recombination, and replication, and can alter local chromatin architecture. Understanding histone modifications is key to uncovering epigenetic mechanisms of gene regulation. Merck grasps the complexity of this research and provides a growing line of kits, antibodies, and assays for studying histones and their modifications. Merck offers over 600 validated antibodies, recombinant proteins, and kits to analyze histone and histone-variant phosphorylation, methylation, acetylation, ubiquitination, and citrullination-the most widely studied histone modifications in epigenetics today.